HG106 is a potent SLC7A11 inhibitor. HG106 markedly decreased cystine uptake and intracellular glutathione biosynthesis. HG106 can be used for the research of KRAS-mutant lung adenocarcinoma[1].
Molecular Weight:
316.74
Purity:
99.95
CAS Number:
[928712-10-1]
Formula:
C15H13ClN4O2
Target:
Others
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted